15Sep/17

The generic drug industry has brought huge cost savings. That may be changing.

A decade ago, physicians who treat epilepsy got what seemed like a piece of good news: Eight companies had received federal approval to sell a generic version of an injectable lifesaving drug.Read More…

27Jul/17

Gilead’s hepatitis C franchise breaks out of a rut, but the M&A drumbeat continues

Gilead Sciences made an unexpected turnabout in the second quarter, with hepatitis C sales finding firmer ground after a long slog through quarter after quarter of slough. The hep C franchise, whichRead More…

26May/17

Increasing Flurry of FDA Orphan Drug Development Activity Fueling Uptick of Enthusiasm for Few Pharma Stocks

The healthcare sector which includes biotech, pharmaceutical, and medical device stocks, continues to forge ahead despite recent concerns in the markets as some of the larger companies show attractive earnings growth potentialRead More…

06Apr/17

Biotech, the New ‘Fire’

We suspect that somewhere around the Stone Age, our African ancestors learned to do something that would change the evolutionary cycle of humanity; they learned to control fire. I can’t imagine theRead More…

11Aug/13

FDA May Soon Allow Generic Drug Makers to Update Safety Information On Pharmaceutical Labels

A Pharmaceutical Label Can Be Updated Sooner by Marie Ellis of Medical News Today Present Food and Drug Administration (FDA) regulations prohibit generic drug manufacturers from updating a product’s safety on theRead More…